Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
Cancer Chemotherapy and Pharmacology|April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group StudyTiciana B Leal, Scot C Remick, Chris H Takimoto, et al.
The Lancet. Oncology|September 15, 2014
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 studyJoyce F Liu, William T Barry, Michael Birrer, et al.
Biochemical and Biophysical Research Communications|May 1, 2016
Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent mannerSusan F Fitzpatrick, Zsolt Fábián, Bettina Schaible, et al.
Scientific Reports|August 18, 2016
REST is a hypoxia-responsive transcriptional repressorMiguel A S Cavadas, Marion Mesnieres, Bianca Crifo, et al.
Investigational New Drugs|May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudyRoisin M Connolly, Eric Laille, Ulka Vaishampayan, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 8, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunctionPei Jye Voon, Eric X Chen, Helen X Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research StatementEdward S Kim, Thomas S Uldrick, Caroline Schenkel, et al.
Journal of the National Cancer Institute|December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in OncologyBrian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.
Arthritis and Rheumatism|July 24, 2001
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or kneeT Pincus, G G Koch, T Sokka, et al.
Pageof 30